The medical device company is a privately held and is developing minimally invasive solutions addressing the cervical spine market. In 2013, it received 510(k) clearance from the U.S. Food and Drug Administration for DTRAX Cervical Cage, an implant and delivery system for cervical fusion procedures.
The Series C funding will be used for investment in U.S. sales, marketing, training and clinical activities for the commercialization of DTRAX Cervical Cage.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
